Plain-English translation of NCT07531264 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new rehabilitation approach called NICE (Neuro-Intermuscular Coordination Enhancement) designed for people living with long-term arm weakness after a stroke. The program uses a computer screen and real-time feedback from sensors on your arm muscles to help you relearn how to coordinate those muscles properly. By practicing targeted exercises, the goal is to improve your arm strength, control, and ability to do everyday activities.
Stroke is the leading cause of long-term disability in America, and many stroke survivors struggle with arm weakness that affects their independence and quality of life. This trial exists because doctors need better, more effective ways to help people regain arm function years after their stroke.
You would visit the research center three times per week for six weeks (18 sessions total). During each session, you would perform exercises where sensors on your arm measure your muscle activity, and you would use that feedback to move a cursor on a computer screen to hit targets. Your progress would be tracked with assessments at the start, right after the program ends, and again at 10 and 18 weeks later to see how much your arm function improves.
AI-generated summary from trial data · Jun 21, 2026 · Not medical advice
United States